Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain

Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Metastatic Prostate Cancer

(2015) Victoria Hillerdal et al.   BIODRUGS

Current Clinical Trials Testing Combinations of Immunotherapy and Radiation

(2015) Marka Crittenden et al.   SEMINARS IN RADIATION ONCOLOGY

Immunotherapy in Metastatic Renal Cell Carcinoma: A Comprehensive Review

(2015) Rachna Raman et al.   Biomed Research International

Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival

(2015) Aurelie Poli et al.   Oncotarget

Metastases in Immune-Mediated Dormancy: A New Opportunity for Targeting Cancer

(2014) I. Romero et al.   CANCER RESEARCH

Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanisms

(2014) Ahrathy Selathurai et al.   CARDIOVASCULAR RESEARCH

Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective

(2014) Loretta Gammaitoni et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

The Ly49 natural killer cell receptors: a versatile tool for viral self-discrimination

(2014) Richard Berry et al.   IMMUNOLOGY AND CELL BIOLOGY

Active immunotherapy using dendritic cells in the treatment of glioblastoma multiforme

(2013) Amade Bregy et al.   CANCER TREATMENT REVIEWS

NK cell-based immunotherapy for malignant diseases

(2013) Min Cheng et al.   Cellular & Molecular Immunology

Immunology of cancer stem cells in solid tumours. A review

(2013) Cristina Maccalli et al.   EUROPEAN JOURNAL OF CANCER

Natural killer cell biology: An update and future directions

(2013) Kerry S. Campbell et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In Vivo

(2013) Okjae Lim et al.   PLoS One

Leptomeningeal and intramedullary metastases of glioblastoma multiforme in a patient reoperated during adjuvant radiochemotherapy

(2013) Josip Joachim Grah et al.   World Journal of Surgical Oncology

Patient-Specific Orthotopic Glioblastoma Xenograft Models Recapitulate the Histopathology and Biology of Human Glioblastomas In Situ

(2013) Kyeung Min Joo et al.   Cell Reports

Adoptive Cell Therapies for Glioblastoma

(2013) Kevin Bielamowicz et al.   Frontiers in Oncology

Immunotherapy of Malignant Gliomas Using Autologous and Allogeneic Tissue Cells

(2012) F. M. Hofman et al.   Anti-Cancer Agents in Medicinal Chemistry

Human Glioblastoma Stem-Like Cells are More Sensitive to Allogeneic NK and T Cell-Mediated Killing Compared with Serum-Cultured Glioblastoma Cells

(2011) Tony Avril et al.   BRAIN PATHOLOGY

Rare Phenomenon: Liver Metastases From Glioblastoma Multiforme

(2011) Stefan S. Schönsteiner et al.   JOURNAL OF CLINICAL ONCOLOGY

Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know

(2011) Steven A. Rosenberg   Nature Reviews Clinical Oncology

Natural Killer Cells: From Basic Research to Treatments

(2011) Eric Vivier et al.   Frontiers in Immunology

Extra-Neural Metastases of Malignant Gliomas: Myth or Reality?

(2011) Patrick Beauchesne   Cancers

Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients

(2010) T. Di Tomaso et al.   CLINICAL CANCER RESEARCH

Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research

(2010) Carol Kilkenny et al.   PLOS BIOLOGY

Immunotherapy of distant metastatic disease

(2009) D. Schadendorf et al.   ANNALS OF ONCOLOGY

Fibronectin maintains survival of mouse natural killer (NK) cells via CD11b/Src/ -catenin pathway

(2009) T. Zhang et al.   BLOOD

Targeted Therapies to Improve Tumor Immunotherapy

(2008) J. Begley et al.   CLINICAL CANCER RESEARCH

Malignant Gliomas in Adults

(2008) Patrick Y. Wen et al.   NEW ENGLAND JOURNAL OF MEDICINE